Roche Holding AG (RHHBY)
32.18
-0.46
(-1.41%)
USD |
OTCM |
Mar 18, 16:05
Roche Market Cap: 205.24B for March 18, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
March 15, 2024 | 208.18B |
March 14, 2024 | 209.77B |
March 13, 2024 | 218.25B |
March 12, 2024 | 224.18B |
March 11, 2024 | 220.74B |
March 08, 2024 | 216.21B |
March 07, 2024 | 215.38B |
March 06, 2024 | 213.47B |
March 05, 2024 | 211.43B |
March 04, 2024 | 209.71B |
March 01, 2024 | 210.98B |
February 29, 2024 | 208.75B |
February 28, 2024 | 210.03B |
February 27, 2024 | 210.66B |
February 26, 2024 | 207.41B |
February 23, 2024 | 210.22B |
February 22, 2024 | 207.22B |
February 21, 2024 | 209.90B |
February 20, 2024 | 208.81B |
February 16, 2024 | 205.88B |
February 15, 2024 | 204.73B |
February 14, 2024 | 204.22B |
February 13, 2024 | 204.92B |
February 12, 2024 | 207.92B |
February 09, 2024 | 206.07B |
Date | Value |
---|---|
February 08, 2024 | 204.73B |
February 07, 2024 | 207.60B |
February 06, 2024 | 212.19B |
February 05, 2024 | 211.49B |
February 02, 2024 | 216.53B |
February 01, 2024 | 218.89B |
January 31, 2024 | 224.12B |
January 30, 2024 | 228.84B |
January 29, 2024 | 228.46B |
January 26, 2024 | 227.31B |
January 25, 2024 | 222.33B |
January 24, 2024 | 225.01B |
January 23, 2024 | 223.87B |
January 22, 2024 | 226.61B |
January 19, 2024 | 225.40B |
January 18, 2024 | 225.97B |
January 17, 2024 | 227.05B |
January 16, 2024 | 231.52B |
January 12, 2024 | 235.79B |
January 11, 2024 | 234.13B |
January 10, 2024 | 236.94B |
January 09, 2024 | 235.60B |
January 08, 2024 | 237.90B |
January 05, 2024 | 236.17B |
January 04, 2024 | 238.92B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
204.22B
Minimum
Feb 14 2024
357.42B
Maximum
Dec 28 2021
271.95B
Average
267.52B
Median
Sep 19 2022
Market Cap Benchmarks
Novartis AG | 196.08B |
Pfizer Inc | 156.67B |
Gilead Sciences Inc | 91.27B |
Eli Lilly and Co | 724.65B |
CRISPR Therapeutics AG | 5.732B |
Market Cap Related Metrics
PE Ratio | 16.08 |
PS Ratio | 3.057 |
Price to Book Value | 5.881 |
Price to Free Cash Flow | 16.14 |
Price | 32.18 |
Earnings Yield | 6.22% |
Operating PE Ratio | 12.02 |
Normalized PE Ratio | 15.90 |